FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01

Wednesday, September 16, 2026John SterlingView original

The partnership marks Cellares’ first collaboration with a cell therapy developer in Asia and will evaluate automated manufacturing of GenomeFrontier’s virus-free CAR T process for clinical manufacturing in the U.S.

The post Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01 appeared first on GEN - Genetic Engineering and Biotechnology News.